Myriad Genetics | MYGN - Ordinary Share Capital


Myriad Genetics reported $93.5M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Agilent USD 281.97M 252K Jun/2026
Becton, Dickinson and Co. USD 272.39M 98.21M Sep/2026
Bio-Rad Laboratories USD 26.74M 91K Jun/2026
Bruker USD 152.35M 130K Jun/2026
Danaher USD 703.4M 500K Sep/2026
Illumina USD 151.3M 607K Jun/2026
J&J USD 2.41B 1.64M Jun/2026
Mettler Toledo International USD 20.21M 40.9K Jun/2026
Myriad Genetics USD 93.5M 400K Dec/2025
OraSure Technologies USD 70.39M 1.87M Dec/2025
Pacific Biosciences Of California USD 301.96M 103K Dec/2025
Quest Diagnostics USD 110M 0 Sep/2026
Quidel USD 68.3M 200K Jun/2026
Repligen USD 56.69M 266K Sep/2026
Revvity USD 111.59M 43K Sep/2026
Standard Biotools USD 392.12M 1.98M Jun/2026
Thermo Fisher Scientific USD 369.75M 1.88M Sep/2026
Veracyte USD 80.39M 598K Sep/2026
Waters USD 98.19M 20K Jun/2026